Will India approve more GMO crops? ‘Ideological’ regulators could halt progress


The apex regulator of genetically-modified (GM) crops has permitted a Jalna, Maharashtra-based seed company to do confined bio-safety trials on borer-resistant brinjal …. The move has gladdened the agri-biotechnology industry. “This is a step in the right direction,” said Ram Kaundinya, director-general of the Federation of Seed Industry of India ….

But …. [b]oth the [federal government] and the states have strong ideological positions on GM crops, particularly edible ones. Their no-objection is needed for the trials to be conducted. Bihar’s chief minister Nitish Kumar, for instance, is unlikely to permit the trials.

Even before the GEAC approved and recommended GM mustard for commercial cultivation in May 2017, Kumar had written to the Prime Minister to overrule a technical subcommittee of the GEAC that had declared GM mustard safe for large-scale cultivation. He had termed genetic engineering as a ‘hazardous’ technology. The state [did not permit] trials of Bt brinjal is 2009 on the advice of farmers and the state farmers’ commission, he said.


Related article:  Judge orders FDA to assess potential impact of escaped GM AquAdvantage salmon on wild fish

The government’s emphasis on ease of doing business does not seem to apply to agricultural biotechnology. The regulatory process is dilatory and wears the applicants down. Beej Sheetal [Research] had conducted the phase-1 bio-safety research trials at Jalna, Guntur and Varanasi in 2009 and 2010. Phase-2 trials happened six years later in 2016-17 in Maharashtra, Punjab, Gujarat, Haryana, Uttar Pradesh, Delhi and Andhra Pradesh. The trials will be repeated now in another set of eight states.

Even if …. GM brinjal hybrids are declared safe in the trials, the approval for commercial cultivation is not guaranteed. The ultimate decision rests on the environment minister who may give more weight to political considerations than to scientific evidence.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend